CG ONCOLOGY INC (CGON:NASDAQ)
$74.81 -0.35 (-0.4657%)
Analysed CG ONCOLOGY INC (CGON:NASDAQ) News Sources
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
16-07-2026
yahoo.com
Assessing CG Oncology (CGON) Valuation After Positive Phase 2 CORE-008 Bladder Cancer Data
17-05-2026
yahoo.com
CG Oncology to Present at Upcoming Investor Conferences in June
28-05-2026
yahoo.com
Did CG Oncology’s Leadership Consolidation Around CEO Kuan Just Shift CGON’s Commercialization Narrative?
31-05-2026
yahoo.com
CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push
07-06-2026
marketbeat.com
CG Oncology Eyes Bladder Cancer Breakthrough With Phase 3 Data, Q4 Filing Ahead
10-06-2026
marketbeat.com
CG Oncology Stock Gains 12% in Three Months: What's Driving It?
13-07-2026
yahoo.com
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
27-07-2026
yahoo.com
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
06-08-2026
yahoo.com
Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
26-08-2026
yahoo.com
What is the current price of CG ONCOLOGY INC (CGON:NASDAQ)?
The current price of CG ONCOLOGY INC (CGON:NASDAQ) is $74.81.
CG ONCOLOGY INC (CGON:NASDAQ) absolute price change since previous trading day?
The absolute price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is $-0.35.
CG ONCOLOGY INC (CGON:NASDAQ) percentage price change since previous trading day?
The percentage price change of CG ONCOLOGY INC (CGON:NASDAQ) since the previous trading day is -0.4657%.
What is the most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent average sentiment score for CG ONCOLOGY INC (CGON:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for CG ONCOLOGY INC (CGON:NASDAQ)?
The most recent sentiment for CG ONCOLOGY INC (CGON:NASDAQ) is .
SEC-8K** Filing Available For CG ONCOLOGY INC (CGON:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.